Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients E. BlankN. WillichF. Wenz Original article 14 January 2012 Pages: 113 - 119
Dosimetric integration of daily mega-voltage cone-beam CT for image-guided intensity-modulated radiotherapy A. Zabel-du BoisS. NillA. Schwahofer Original article 05 January 2012 Pages: 120 - 126
Breast cancer and funnel chest M. UhlF. SterzingK. Herfarth Original article 06 January 2012 Pages: 127 - 135
Salvage radiotherapy in patients with recurrent esophageal carcinoma K. FakhrianN. GamischH. Geinitz Original article 06 January 2012 Pages: 136 - 142
Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis D. RadesJ.D. KueterS.E. Schild Original article 12 January 2012 Pages: 143 - 147
Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors C. GaniA.C. MüllerB. Berger Original article 11 January 2012 Pages: 148 - 153
Radiotherapy with and without temozolomide in elderly patients with glioblastoma M. NiyaziS.B. SchwarzC. Belka Original article 11 January 2012 Pages: 154 - 159
Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy I. FotinaC. Lütgendorf-CaucigD. Georg Original article 27 January 2012 Pages: 160 - 167
Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation C. BlattmannS. OertelV. Ehemann Original article 18 January 2012 Pages: 168 - 176
Radiosensitizing effect of epothilone B on human epithelial cancer cells T. BaumgartG. KlautkeK. Manda Original article 12 January 2012 Pages: 177 - 184
Numerical deconvolution to enhance sharpness and contrast of portal images for radiotherapy patient positioning verification H.K. LooeY. UphoffK.C. Willborn Original article 12 January 2012 Pages: 185 - 190
Regionäre Lymphknoten, Satelliten und TNM: Werden wir besser? C. Wittekind Literatur kommentiert 11 January 2012 Pages: 191 - 192
Trotz geringer dosislimitierender Toxizität ist Vorsicht bei der extrem hypofraktionierten Dosiseskalation mithilfe Körperstereotaxie (SBRT) bei frühen Prostatakarzinomen mit niedrigem oder intermediärem Risikoprofil geboten M. Bremer Literatur kommentiert 06 January 2012 Pages: 192 - 193
RTOG-Studie 0324: Cetuximab bei Patienten mit nicht-kleinzelligem Bronchialkarzinom C. Nieder Literatur kommentiert 06 January 2012 Pages: 194 - 195
Capecitabin plus Oxaliplatin verglichen mit Fluorouracil und Folinsäure als adjuvante Therapie bei Kolonkarzinom im Stadium III D. Arnold Literatur kommentiert 06 January 2012 Pages: 196 - 197
Adressen, Personalia, Preisausschreibung, Tagungen Mitteilungen der Fachgesellschaften 27 September 2013 Pages: 198 - 200